RedHill Biopharma (RDHL) Cash from Financing Activities (2012 - 2023)
RedHill Biopharma's Cash from Financing Activities was $7.32 million in the year ended Dec 31, 2025, down 13.1% from $8.42 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Cash from Financing Activities (2012 - 2023) Analysis & Trends
From the year ended Dec 31, 2010 onward, RedHill Biopharma has reported Cash from Financing Activities for 16 years.
- Cash from Financing Activities shows a five-year compound annual growth rate of -38.7% (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 marks the lowest annual Cash from Financing Activities since the year ended Dec 31, 2013.
- Per Business Quant data, Cash from Financing Activities in earlier years was $8.42 million in the year ended Dec 31, 2024 (-60.7%), $21.44 million in the year ended Dec 31, 2023 (+87.2%), $11.45 million in the year ended Dec 31, 2022 (-84.4%) and $73.46 million in the year ended Dec 31, 2021 (-12.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -3.66 Bn |
| 10 | RedHill Biopharma | 1.44 Mn | -15.18 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 4.81 Mn |
| Dec 31, 2022 | 7.20 Mn |
| Sep 30, 2022 | -5.72 Mn |
| Jun 30, 2022 | 14.92 Mn |
| Mar 31, 2022 | -4.94 Mn |
| Dec 31, 2021 | 17.57 Mn |
| Sep 30, 2021 | -999,000.00 |
| Jun 30, 2021 | -1.77 Mn |
| Mar 31, 2021 | 58.66 Mn |
| Dec 31, 2020 | 7.94 Mn |
| Sep 30, 2020 | 11.96 Mn |
| Jun 30, 2020 | 5.46 Mn |
| Mar 31, 2020 | 59.08 Mn |
| Dec 31, 2019 | 36.10 Mn |
| Sep 30, 2019 | -206,000.00 |
| Jun 30, 2019 | -199,000.00 |
| Mar 31, 2019 | -186,000.00 |
| Dec 31, 2018 | 18.36 Mn |
| Sep 30, 2018 | 23.55 Mn |
API Access
RedHill Biopharma Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();